Neuraxis (NRXS)

Neuraxis Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:NRXS

1 2 Next >>

Date	Time	Source	Headline	Symbol	Company
07/06/2024	14:00	GlobeNewswire Inc.	NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit Disclosure	AMEX:NRXS	Neuraxis Inc
22/05/2024	13:00	GlobeNewswire Inc.	NeurAxis Reports First Quarter 2024 Financial Results	AMEX:NRXS	Neuraxis Inc
21/05/2024	14:00	GlobeNewswire Inc.	NeurAxis to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024	AMEX:NRXS	Neuraxis Inc
20/05/2024	21:18	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	AMEX:NRXS	Neuraxis Inc
16/05/2024	14:00	GlobeNewswire Inc.	NeurAxis Announces New Medical Policy Coverage For Nearly Six Million Lives in Florida	AMEX:NRXS	Neuraxis Inc
15/05/2024	21:30	GlobeNewswire Inc.	NeurAxis to Host First Quarter 2024 Results and Business Update Call on Wednesday, May 22, 2024	AMEX:NRXS	Neuraxis Inc
15/05/2024	21:15	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	AMEX:NRXS	Neuraxis Inc
23/04/2024	14:00	GlobeNewswire Inc.	NeurAxis Announces New Medical Policy Coverage in North Dakota	AMEX:NRXS	Neuraxis Inc
09/04/2024	21:05	GlobeNewswire Inc.	NeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial Results	AMEX:NRXS	Neuraxis Inc
01/04/2024	21:15	GlobeNewswire Inc.	NeurAxis to Host Fourth Quarter and Full Year 2023 Results and Business Update Call on Tuesday, April 9, 2024	AMEX:NRXS	Neuraxis Inc
27/03/2024	13:00	GlobeNewswire Inc.	NeurAxis Announces IB-Stim Results from a Large, Pediatric, Multi-Center Registry	AMEX:NRXS	Neuraxis Inc
11/03/2024	13:00	GlobeNewswire Inc.	NeurAxis Announces Highmark BCBS Policy Coverage	AMEX:NRXS	Neuraxis Inc
11/03/2024	12:50	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:NRXS	Neuraxis Inc
04/03/2024	14:00	GlobeNewswire Inc.	NeurAxis Announces Blue Cross and Blue Shield of Kansas City Policy Coverage	AMEX:NRXS	Neuraxis Inc
27/02/2024	16:00	GlobeNewswire Inc.	NeurAxis to Present at Oppenheimer 34th Annual Healthcare MedTech & Services Conference	AMEX:NRXS	Neuraxis Inc
15/02/2024	22:00	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:NRXS	Neuraxis Inc
31/01/2024	14:15	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:NRXS	Neuraxis Inc
20/12/2023	14:00	GlobeNewswire Inc.	NeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive Officer	AMEX:NRXS	Neuraxis Inc
19/12/2023	22:05	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	AMEX:NRXS	Neuraxis Inc
19/12/2023	22:00	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:NRXS	Neuraxis Inc
20/11/2023	22:30	GlobeNewswire Inc.	NeurAxis Reports Third Quarter 2023 Financial Results	AMEX:NRXS	Neuraxis Inc
20/11/2023	22:15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	AMEX:NRXS	Neuraxis Inc
15/11/2023	14:00	GlobeNewswire Inc.	NeurAxis Announces CareFirst BCBS Policy Coverage	AMEX:NRXS	Neuraxis Inc
14/11/2023	14:00	GlobeNewswire Inc.	NeurAxis Secures $3 Million Financing	AMEX:NRXS	Neuraxis Inc
08/11/2023	14:00	GlobeNewswire Inc.	NeurAxis Signs Exclusive Option Agreement with University of Michigan for Innovative Gastrointestinal Device	AMEX:NRXS	Neuraxis Inc
26/09/2023	14:00	GlobeNewswire Inc.	NeurAxis Announces Results of Comparative Study of IB-Stim™ and Standard Medical Therapy in Adolescents with Functional Abdominal Pain Disorders	AMEX:NRXS	Neuraxis Inc
22/09/2023	21:16	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	AMEX:NRXS	Neuraxis Inc
21/09/2023	13:30	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:NRXS	Neuraxis Inc
21/09/2023	13:00	GlobeNewswire Inc.	NeurAxis Reports Second Quarter 2023 Financial Results	AMEX:NRXS	Neuraxis Inc
13/09/2023	21:15	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	AMEX:NRXS	Neuraxis Inc